Clinical trial

Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer

NCT03598257

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

PROCEDURE · Unmapped registry intervention Biospecimen Collection Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Olaparib Normalized identity: olaparibView linked drug · Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention Radiation Therapy Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Survey Administration Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2019-01-18

PhasePHASE2

Conditions

Breast Inflammatory Carcinomaunresolved

Interventions

Biospecimen CollectionPROCEDURE

OlaparibDRUG · verified · RxNorm: olaparib

Radiation TherapyRADIATION

Survey AdministrationOTHER

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

AtlantaGeorgia, United States4 ChicagoIllinois, United States3 St LouisMissouri, United States3 AlbuquerqueNew Mexico, United States3 HoustonTexas, United States2 Los AngelesCalifornia, United States2 SeattleWashington, United States2 CincinnatiOhio, United States2 PortlandOregon, United States2 IndianapolisIndiana, United States2 Oklahoma CityOklahoma, United States2 OmahaNebraska, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03598257 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.